Quick Answer
FINRA's research-analyst conflicts rule requires written policies to identify and manage analyst conflicts, promote objective research, and prevent research being used as an IB marketing tool. Mechanics: an information barrier, no IB pre-publication review, managed IB contact, no IB-driven compensation, annual compensation-committee review excluding IB, anti-retaliation protection, and personal-trading restrictions barring front-running and trading against the analyst's latest recommendation.
The research-analyst conflicts rule's central premise is that research analysts face a structural conflict: their firm earns investment banking fees from the same companies the analysts cover. Without a hard barrier, IB can pressure analysts to upgrade or initiate coverage on potential clients, suppress sell ratings on existing clients, and tie analyst compensation to deal flow.
The rule addresses the conflict by mandating a written framework, structural separation, and personal-trading discipline.
Written Policies and Procedures Requirement
Each member firm must adopt and implement written policies and procedures reasonably designed to:
- Identify and manage conflicts of interest involving research analysts
- Promote objective and reliable research
- Prevent the use of research as a marketing tool for investment banking
Adoption and supervision is a principal-level responsibility, split across two separate roles rather than held by one dual-licensed person. The General Securities Principal (Series 24) owns the overall framework; the Supervisory Analyst (Series 16) approves individual reports before publication, covered later in this unit. A firm can staff these roles with two different people; neither one is required to hold both qualifications.
The firm's WSPs (written supervisory procedures, covered in the Written Supervisory Procedures and Controls unit) must include the research-analyst-conflicts procedures or cross-reference a separate research-supervision manual.
The principal does not personally write each research report. The principal designs and maintains the system that ensures every report is produced, reviewed, and disclosed inside the research-analyst-conflicts framework.
Exam Tip: Gotchas
- The research-analyst conflicts rule is a procedure rule. The firm's obligation is to adopt and implement written procedures, not to guarantee any individual analyst's independence in the abstract. A firm with no procedures in place is in violation even if its analysts happen to be objective.
- The marketing-tool prohibition is the substantive heart. The firm cannot use research as an investment-banking sales tool. A research report distributed during a pitch as a deal-promotion device is the textbook violation.
Information Barriers Between Research and Investment Banking
The information barrier is the structural separation between the research department and investment banking that prevents IB from steering research conclusions:
| Restriction | What It Means |
|---|---|
| No IB pre-publication review | Investment banking personnel may NOT review or approve a research report before publication. Sections of a draft may be sent to non-investment-banking personnel, or to the subject company, for factual review (coordinated through legal/compliance) - that factual-review path does not run to investment banking |
| Research holds coverage decisions | Research management makes every final coverage decision; IB cannot direct who gets covered or who gets dropped. The firm must restrict or limit IB input into coverage decisions, not ban it: IB or any other department, such as sales, may convey customer interest or offer input, but research management decides independently and analysts must be insulated from pressure |
| Managed IB-research contact | The firm's written policies must identify and manage the conflicts in contact between analysts and IB, and insulate analysts from IB review, pressure, or oversight. FINRA's rule sets no chaperone requirement; a firm may route these communications through legal/compliance as its own procedure, and its people must then follow it |
| No analyst participation in deal pitches | Research analysts may NOT participate in IB solicitation activities, road shows, or deal pitches. A narrow exception lets an analyst attend a pitch meeting for an Emerging Growth Company (EGC) IPO, but the analyst may not engage in otherwise-prohibited conduct there |
| No marketing direction to analysts | IB may NOT, directly or indirectly, direct an analyst to engage in sales or marketing efforts related to an investment banking deal, or to engage in any communication with a current or prospective customer about an investment banking deal |
The information barrier is not a wall in the abstract sense; it is a set of operational rules with documented exceptions. A firm commonly evidences these safeguards with records of analyst-IB communications and of coverage decisions. The rule requires the safeguards; the firm's own procedures decide which records show they work.
Due diligence has a timing line. An analyst may not perform joint due diligence (confirming the adequacy of disclosure in the offering document) in the presence of investment banking personnel before the issuer has selected its underwriters. After that selection, the prohibition no longer applies.
FINRA also does not apply the joint due-diligence prohibition to a communication with the management of an EGC that both the analyst and an investment banker attend, because the Jumpstart Our Business Startups (JOBS) Act bars FINRA from restricting that communication.
Exam Tip: Gotchas
- Factual review does not run to investment banking. Legal and compliance may route sections of a draft to non-IB personnel or the subject company to verify facts (a deal-size figure, a management biography). Investment banking may not review the draft before publication at all.
- The only pitch-meeting exception is an EGC IPO. An analyst may attend a pitch meeting for an Emerging Growth Company IPO, but may not engage in otherwise-prohibited conduct. A legal or compliance officer in the room does not open any other pitch to an analyst.
- Coverage decisions belong to research. IB may pass along customer interest, within limits the firm's procedures set, but may never direct coverage. An IB instruction to "initiate coverage on Issuer X because we are pitching them" is banking directing coverage; research management decides independently.
Research Analyst Compensation
Compensation is the rule's most heavily tested area because compensation is the most direct lever IB can pull on research:
- A research analyst's compensation may NOT be tied, directly or indirectly, to specific investment banking transactions or to specific deal-related contributions of investment banking
- Compensation must be reviewed and approved at least annually by a compensation committee that does NOT include representatives of investment banking
- The committee must document the basis for each analyst's compensation, considering:
- The analyst's performance on quality and accuracy of research
- The analyst's productivity
- The correlation between the analyst's recommendations and the actual performance of the recommended securities
- Independent ratings of the analyst from clients, the firm's sales force, and peers
- NOT the analyst's contribution to investment banking revenues
- Final research-analyst compensation determinations may NOT be made by investment banking personnel
The "indirectly tied" prong matters. A bonus pool for research analysts that is sized by the firm's overall investment banking revenues (even if individual allocations are not tied to specific deals) is at risk under the research-analyst conflicts rule because the pool itself is IB-revenue-driven. The committee's documentation has to show how each individual award was made and what factors drove it.
Exam Tip: Gotchas
- The compensation committee that sets analyst pay must EXCLUDE investment banking representatives. This is a structural rule. An IB head who sits on the comp committee is the per-se violation, even if the IB head's actual votes were neutral.
- Indirect ties count. Compensation tied to specific deals is the obvious violation; a bonus pool sized by IB revenues is the subtler one. Both fail the test.
- The committee must DOCUMENT the basis for each analyst's pay. The exam tests procedure as well as substance. A comp committee that meets and decides without documentation has not satisfied the research-analyst conflicts rule.
Anti-Retaliation
The anti-retaliation rule shields analysts who publish unfavorable research:
- The firm and its associated persons may NOT directly or indirectly retaliate or threaten retaliation against a research analyst for adverse, negative, or otherwise unfavorable research, opinions, or public appearances that may adversely affect the firm's investment banking relationships
The textbook violation: an analyst issues a sell rating on a company that is also the firm's IB client. The IB head complains to the head of research. The head of research cuts the analyst's bonus, demotes the analyst, or fires the analyst. The retaliation is direct and the rule is violated.
Indirect retaliation also qualifies, including blacklisting an analyst from the firm's most desirable coverage assignments, freezing them out of management meetings, or denying them resources.
The principal supervising research has to be alert to retaliation that masquerades as a normal business decision. A demotion shortly after a sell rating that cost the firm a deal is a fact pattern that will appear on the Series 24 exam.
Exam Tip: Gotchas
- Retaliation does not require firing. A bonus cut, a demotion, a transfer to a less desirable beat, or an exclusion from management access can all be retaliation if the timing and substance line up with adverse research.
- "Threatened" retaliation also violates the rule. A warning from the IB head to the analyst that "your job depends on being more constructive" is itself a violation, even if no retaliatory action follows.
- The defense is documented, contemporaneous, performance-based reasoning. A bonus cut that was decided at the regular comp-committee meeting based on documented performance metrics survives review; a bonus cut decided in an off-cycle meeting after a sell rating cost a deal does not.
Personal-Trading Restrictions on Research Analysts
Analysts and persons able to influence research content face three separate trading restrictions:
| Restriction | What It Prohibits |
|---|---|
| Pre-publication / front-running prohibition | An analyst, supervisor, or person able to influence research content may NOT trade in a manner that benefits from advance knowledge of the content or timing of a research report before intended recipients have had a reasonable opportunity to act on it |
| Trading inconsistent with most recent recommendation | An analyst may NOT trade in a manner inconsistent with the analyst's most recent published recommendation (firms may define limited financial-hardship exceptions, but the default is a hard prohibition) |
| Pre-IPO purchase prohibition | A research-analyst account may NOT purchase or receive a security before the issuer's initial public offering if the issuer is principally engaged in the same type of business as the companies the analyst covers |
These restrictions extend to derivatives of the covered security and to funds whose performance is materially dependent on the security. An analyst with a buy rating on Issuer X cannot short Issuer X, cannot buy puts on Issuer X, cannot short an exchange-traded fund (ETF) heavily concentrated in Issuer X, and cannot trade ahead of the analyst's pending upgrade.
The "persons able to influence" prong sweeps in the analyst's supervisor, the desk strategist who edits drafts, and any executive with substantive editorial input. This is exactly the Exchange Act "influence" parallel from the prior section.
Exam Tip: Gotchas
- The trading restriction extends beyond the analyst. Anyone able to influence the content of a research report is subject to the front-running and trading-against-recommendation prohibitions. The supervisor, the editor, and the desk head are all covered.
- Derivatives and funds are inside the restriction. An analyst with a buy rating on Issuer X who shorts a sector ETF that is materially dependent on Issuer X has traded inconsistent with the recommendation, even though the ETF is not the rated security.
- Financial-hardship exceptions are firm-defined and narrow. Default is no inconsistent trading. The firm can carve out a hardship exception in its WSPs, but the exception has to be documented and supervised.
What Should You Check on Exam Day?
- Can you state why investment banking may never review a research report before publication, even though factual review can route to non-IB personnel?
- Can you say when an analyst may not do due diligence with bankers present, and why a compliance officer in the room changes nothing under FINRA's rule?
- Do you know why a bonus pool sized by firm-wide investment banking revenue can violate the rule even without deal-specific compensation ties?
- Can you state that threatened retaliation against a research analyst violates the rule, even if no retaliatory action ever follows?
- Do you know the three personal-trading restrictions on analysts: front-running, trading against the latest recommendation, and pre-IPO purchases in the same industry?